Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALDX |
---|---|---|
09:32 ET | 6237 | 3.77 |
09:34 ET | 2098 | 3.76 |
09:36 ET | 520 | 3.77 |
09:38 ET | 1760 | 3.78 |
09:41 ET | 100 | 3.81 |
09:43 ET | 500 | 3.79 |
09:45 ET | 100 | 3.79 |
09:48 ET | 246 | 3.79 |
09:50 ET | 775 | 3.79 |
09:52 ET | 9995 | 3.78 |
09:54 ET | 8172 | 3.75 |
09:56 ET | 100 | 3.76 |
10:01 ET | 1861 | 3.77 |
10:03 ET | 264 | 3.76 |
10:06 ET | 100 | 3.77 |
10:08 ET | 1300 | 3.77 |
10:10 ET | 2300 | 3.78 |
10:12 ET | 1400 | 3.79 |
10:15 ET | 387 | 3.795 |
10:19 ET | 400 | 3.79 |
10:21 ET | 1000 | 3.79 |
10:26 ET | 1800 | 3.81 |
10:28 ET | 125 | 3.8164 |
10:30 ET | 525 | 3.82 |
10:32 ET | 5740 | 3.83 |
10:33 ET | 995 | 3.83 |
10:35 ET | 934 | 3.84 |
10:37 ET | 1700 | 3.84 |
10:39 ET | 2200 | 3.85 |
10:44 ET | 400 | 3.855 |
10:46 ET | 2800 | 3.86 |
10:48 ET | 13254 | 3.895 |
10:50 ET | 100 | 3.9 |
10:51 ET | 916 | 3.8915 |
10:53 ET | 200 | 3.9 |
10:55 ET | 400 | 3.9 |
10:57 ET | 1200 | 3.9 |
11:00 ET | 100 | 3.9 |
11:04 ET | 5100 | 3.91 |
11:09 ET | 100 | 3.91 |
11:11 ET | 800 | 3.925 |
11:13 ET | 454 | 3.93 |
11:15 ET | 300 | 3.93 |
11:20 ET | 100 | 3.93 |
11:22 ET | 100 | 3.93 |
11:24 ET | 100 | 3.93 |
11:27 ET | 1530 | 3.93 |
11:33 ET | 295 | 3.93 |
11:36 ET | 3170 | 3.9101 |
11:40 ET | 2700 | 3.91 |
11:42 ET | 472 | 3.89 |
11:44 ET | 595 | 3.8902 |
11:45 ET | 8370 | 3.885 |
11:49 ET | 100 | 3.885 |
11:51 ET | 1615 | 3.87 |
11:58 ET | 174 | 3.87 |
12:02 ET | 500 | 3.88 |
12:03 ET | 488 | 3.88 |
12:07 ET | 200 | 3.88 |
12:09 ET | 300 | 3.888 |
12:12 ET | 800 | 3.89 |
12:14 ET | 110 | 3.8826 |
12:16 ET | 100 | 3.9 |
12:20 ET | 100 | 3.9 |
12:23 ET | 100 | 3.9 |
12:25 ET | 2023 | 3.9 |
12:27 ET | 100 | 3.9 |
12:34 ET | 1471 | 3.9 |
12:36 ET | 200 | 3.9 |
12:38 ET | 100 | 3.9 |
12:39 ET | 200 | 3.895 |
12:41 ET | 149 | 3.9 |
12:43 ET | 762 | 3.9 |
12:45 ET | 400 | 3.905 |
12:48 ET | 300 | 3.905 |
12:50 ET | 200 | 3.905 |
12:52 ET | 100 | 3.905 |
12:54 ET | 788 | 3.91 |
12:56 ET | 500 | 3.92 |
12:57 ET | 300 | 3.92 |
12:59 ET | 2600 | 3.915 |
01:01 ET | 1372 | 3.925 |
01:06 ET | 100 | 3.93 |
01:08 ET | 200 | 3.93 |
01:12 ET | 100 | 3.9246 |
01:14 ET | 100 | 3.93 |
01:17 ET | 2230 | 3.94 |
01:21 ET | 200 | 3.94 |
01:24 ET | 1050 | 3.945 |
01:26 ET | 800 | 3.95 |
01:28 ET | 200 | 3.945 |
01:30 ET | 900 | 3.945 |
01:32 ET | 100 | 3.945 |
01:33 ET | 2316 | 3.935 |
01:42 ET | 1999 | 3.92 |
01:46 ET | 1000 | 3.91 |
01:50 ET | 743 | 3.9 |
01:51 ET | 100 | 3.89 |
01:55 ET | 1738 | 3.905 |
02:00 ET | 100 | 3.92 |
02:02 ET | 1200 | 3.91 |
02:06 ET | 1734 | 3.89 |
02:08 ET | 200 | 3.89 |
02:11 ET | 637 | 3.885 |
02:13 ET | 300 | 3.89 |
02:18 ET | 1004 | 3.895 |
02:20 ET | 100 | 3.89 |
02:22 ET | 145 | 3.8911 |
02:26 ET | 1481 | 3.89 |
02:27 ET | 408 | 3.885 |
02:31 ET | 100 | 3.885 |
02:36 ET | 1727 | 3.88 |
02:40 ET | 1000 | 3.8763 |
02:42 ET | 700 | 3.87 |
02:49 ET | 200 | 3.87 |
02:51 ET | 200 | 3.865 |
02:54 ET | 6916 | 3.85 |
02:58 ET | 100 | 3.84 |
03:02 ET | 100 | 3.85 |
03:03 ET | 218 | 3.85 |
03:05 ET | 200 | 3.85 |
03:07 ET | 100 | 3.845 |
03:09 ET | 700 | 3.85 |
03:12 ET | 300 | 3.85 |
03:14 ET | 500 | 3.8421 |
03:16 ET | 300 | 3.86 |
03:18 ET | 500 | 3.86 |
03:23 ET | 350 | 3.8661 |
03:25 ET | 103 | 3.87 |
03:27 ET | 600 | 3.87 |
03:30 ET | 100 | 3.8699 |
03:32 ET | 1500 | 3.87 |
03:34 ET | 766 | 3.88 |
03:38 ET | 310 | 3.875 |
03:39 ET | 5016 | 3.88 |
03:41 ET | 4111 | 3.915 |
03:43 ET | 1002 | 3.91 |
03:48 ET | 2430 | 3.895 |
03:50 ET | 3055 | 3.89 |
03:52 ET | 1000 | 3.9 |
03:54 ET | 400 | 3.91 |
03:56 ET | 1449 | 3.9 |
03:57 ET | 5589 | 3.915 |
03:59 ET | 7911 | 3.91 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Aldeyra Therapeutics Inc | 232.3M | -7.7x | --- |
Candel Therapeutics Inc | 232.0M | -6.1x | --- |
Invivyd Inc | 230.3M | -1.0x | --- |
Cytodyn Inc | 237.5M | -4.3x | --- |
Prelude Therapeutics Inc | 224.7M | -2.2x | --- |
Pyxis Oncology Inc | 224.4M | -2.7x | --- |
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $232.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.39 |
EPS | $-0.51 |
Book Value | $2.02 |
P/E Ratio | -7.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.